Capacity Expansion, HBM4 Roadmap, and Supply-Chain Investment
Key Questions
What is CXMT's current market position and expansion plans?
CXMT holds 7.6% DRAM share (98% commodity, no HBM) after a 500% IPO debut valuing it at $520B. It raised $8.5B and targets 600k wafers per month by end-2026, nearing Micron's capacity.
How does CXMT's pricing threaten incumbent memory makers?
CXMT offers modules at $138 versus $300-400 from established players, raising price war risks. Apple is lobbying to adopt CXMT chips, increasing geopolitical pressure.
Why do Wall Street analysts see limited threat to Micron from CXMT?
Analysts cite Micron's HBM moat and CXMT's commodity-only focus, plus US restrictions and CXMT's HBM lag, as limiting near-term disruption despite long-term overcapacity concerns.
What recent deals highlight CXMT's competitive push?
CXMT secured $7B from ByteDance and $3B from Tencent, intensifying pricing power shifts, though the IPO-driven selloff in Micron, SanDisk, and SK Hynix is viewed as temporary jitters.
What strategic signal does CXMT's massive valuation send?
The $520B valuation after raising funds underscores China's intent to dominate memory, even as Micron directly challenges Apple's push for Chinese chips amid insider selling concerns.
Coverage reiterates reported HBM4 production and H2 2027 targets for 1-delta expansion and G11 NAND, while vHBM mass production is described as a 2028 target with thermal trade-offs that may limit deployment. Recent roadmap and 3D DRAM articles largely repeat prior coverage and provide no new yield, capacity, adoption, or economic evidence; Micron’s critical-mineral investment also has unquantified supply and cost effects.